These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7731147)

  • 1. Intravenous calcitriol normalizes insulin sensitivity in uremic patients.
    Kautzky-Willer A; Pacini G; Barnas U; Ludvik B; Streli C; Graf H; Prager R
    Kidney Int; 1995 Jan; 47(1):200-6. PubMed ID: 7731147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous alfacalcidol improves insulin resistance in hemodialysis patients.
    Günal AI; Celiker H; Celebi H; Ustündağ B; Günal SY
    Clin Nephrol; 1997 Aug; 48(2):109-13. PubMed ID: 9285148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretion in uremia: effect of parathyroid hormone and vitamin D metabolites.
    Mak RH
    Kidney Int Suppl; 1989 Nov; 27():S227-30. PubMed ID: 2699996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD.
    Quarles LD; Yohay DA; Carroll BA; Spritzer CE; Minda SA; Bartholomay D; Lobaugh BA
    Kidney Int; 1994 Jun; 45(6):1710-21. PubMed ID: 7933819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uraemic patients with secondary hyperparathyroidism.
    Lin SH; Lin YF; Lu KC; Diang LK; Chyr SH; Liao WK; Shieh SD
    Clin Sci (Lond); 1994 Nov; 87(5):533-8. PubMed ID: 7874841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of parathyroid hormone in the glucose intolerance of chronic renal failure.
    Akmal M; Massry SG; Goldstein DA; Fanti P; Weisz A; DeFronzo RA
    J Clin Invest; 1985 Mar; 75(3):1037-44. PubMed ID: 3884663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of serum calcium and parathyroid hormone upon glucose metabolism in uremia.
    Amend WJ; Steinberg SM; Lowrie EG; Lazarus JM; Soeldner JS; Hampers CL; Merrill JP
    J Lab Clin Med; 1975 Sep; 86(3):435-44. PubMed ID: 1151160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
    Slatopolsky E; Weerts C; Thielan J; Horst R; Harter H; Martin KJ
    J Clin Invest; 1984 Dec; 74(6):2136-43. PubMed ID: 6549016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol.
    Cannella G; Bonucci E; Rolla D; Ballanti P; Moriero E; De Grandi R; Augeri C; Claudiani F; Di Maio G
    Kidney Int; 1994 Oct; 46(4):1124-32. PubMed ID: 7861707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism.
    Lin SH; Shieh SD; Chyr SH; Lu KC; Lin YF; Diang LK; Chou TC; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):240-5. PubMed ID: 7982134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis.
    Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A
    Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of oral alfacalcidol to oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients.
    Rauscher S; Lafrance JP; Pichette V; Bell RZ; Desforges K; Lepage L; Ouellet G; Ouimet D; Leblanc M; Lamarche C; Bezzaoucha S; Vallee M
    Int Urol Nephrol; 2017 Feb; 49(2):325-328. PubMed ID: 27822674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Grenda R; Qiu P; Restaino I; Wojtak A; Paredes A; Benador N; Melnick JZ; Williams LA; Salusky IB
    Pediatr Nephrol; 2005 May; 20(5):622-30. PubMed ID: 15785941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-induced insulin secretion in uremia: role of 1 alpha,25(HO)2-vitamin D3.
    Allegra V; Luisetto G; Mengozzi G; Martimbianco L; Vasile A
    Nephron; 1994; 68(1):41-7. PubMed ID: 7991039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No difference in intestinal strontium absorption after oral or IV calcitriol in children with secondary hyperparathyroidism. The European Study Group on Vitamin D in Children with Renal Failure.
    Ardissino G; Schmitt CP; Bianchi ML; Daccò V; Claris-Appiani A; Mehls O
    Kidney Int; 2000 Sep; 58(3):981-8. PubMed ID: 10972662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperparathyroidism, glucose tolerance and platelet intracellular free calcium in chronic renal failure.
    Lu KC; Shieh SD; Lin SH; Chyr SH; Lin YF; Diang LK; Li BL; Sheu WH; Ding YA
    Q J Med; 1994 Jun; 87(6):359-65. PubMed ID: 8041868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-Dihydroxyvitamin D3 corrects insulin and lipid abnormalities in uremia.
    Mak RH
    Kidney Int; 1998 May; 53(5):1353-7. PubMed ID: 9573552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
    Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
    Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.